BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

13517

531162

EMAMILTD

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

EMAMI LIMITED performance

Today’s low

Today’s high

₹ 618.05 ₹ 649.00
₹ 619.80

52 week low

52 week high

₹ 437.95 ₹ 860.00
₹ 619.80

Open Price

₹ 649.00

Prev. Close

₹ 645.80

Volume (Shares)

396388.00

Total traded value

₹ 2456.81

Upper Circuit

₹ 774.95

Lower Circuit

₹ 516.65

info

EMAMI LIMITED Share Price Update

As of the latest trading session, EMAMI LIMITED share price is currently at ₹ 619.8, which is down by ₹ -26.00 from its previous closing. Today, the stock has fluctuated between ₹ 618.05 and ₹ 649.00. Over the past year, EMAMI LIMITED has achieved a return of 33.29 %. In the last month alone, the return has been 7.59 %. Read More...

EMAMI LIMITED fundamentals


  • Market cap (Cr)

    27,054.27

  • P/E Ratio (TTM)

    32.95

  • Beta

    0.63

  • Book Value / share

    63.54

  • Return on equity

    29.84%

  • EPS (TTM)

    18.81

  • Dividend yield

    1.29%

  • Net profit/quarter (Cr)

    279.41

info icon alternate text
  • Market cap (Cr)

    27,049.90

  • P/E Ratio (TTM)

    32.95

  • Beta

    0.62

  • Book Value / share

    63.54

  • Return on equity

    29.84%

  • EPS (TTM)

    18.81

  • Dividend yield

    1.29%

  • Net profit/quarter (Cr)

    279.41

info icon alternate text

EMAMI LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 878.64
Operating Expense 590.61
Net Profit 279.41
Net Profit Margin (%) 31.80
Earnings Per Share (EPS) 6.40
EBITDA 338.30
Effective Tax Rate (%) 6.19
Particulars SEP 2024 (Values in Cr)
Revenue 709.01
Operating Expense 522.96
Net Profit 214.10
Net Profit Margin (%) 30.19
Earnings Per Share (EPS) 4.90
EBITDA 260.82
Effective Tax Rate (%) 2.91
Particulars JUN 2024 (Values in Cr)
Revenue 755.30
Operating Expense 603.35
Net Profit 175.98
Net Profit Margin (%) 23.29
Earnings Per Share (EPS) 4.03
EBITDA 238.35
Effective Tax Rate (%) 11.40
Particulars MAR 2024 (Values in Cr)
Revenue 709.43
Operating Expense 564.90
Net Profit 151.75
Net Profit Margin (%) 21.39
Earnings Per Share (EPS) 3.48
EBITDA 214.62
Effective Tax Rate (%) 11.17
Particulars DEC 2023 (Values in Cr)
Revenue 813.06
Operating Expense 571.52
Net Profit 249.04
Net Profit Margin (%) 30.62
Earnings Per Share (EPS) 5.71
EBITDA 302.07
Effective Tax Rate (%) 4.51
Particulars MAR 2024 (Values in Cr)
Revenue 2921.57
Operating Expense 2238.27
Net Profit 693.39
Net Profit Margin (%) 23.73
Earnings Per Share (EPS) 15.86
EBITDA 915.32
Effective Tax Rate (%) 7.13
Particulars MAR 2023 (Values in Cr)
Revenue 2906.83
Operating Expense 2348.50
Net Profit 573.50
Net Profit Margin (%) 19.72
Earnings Per Share (EPS) 13.00
EBITDA 825.44
Effective Tax Rate (%) 5.41
Particulars MAR 2022 (Values in Cr)
Revenue 2866.87
Operating Expense 2300.75
Net Profit 850.68
Net Profit Margin (%) 29.67
Earnings Per Share (EPS) 19.15
EBITDA 1020.12
Effective Tax Rate (%) -23.45
Particulars MAR 2021 (Values in Cr)
Revenue 2582.28
Operating Expense 2112.11
Net Profit 475.13
Net Profit Margin (%) 18.39
Earnings Per Share (EPS) 10.68
EBITDA 947.37
Effective Tax Rate (%) 17.25
Particulars MAR 2020 (Values in Cr)
Revenue 2389.92
Operating Expense 2142.89
Net Profit 289.12
Net Profit Margin (%) 12.09
Earnings Per Share (EPS) 6.37
EBITDA 682.86
Effective Tax Rate (%) 14.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 56.05
ROE % 30.49
ROCE % 31.90
Total Debt to Total Equity 0.04
EBITDA Margin 27.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 52.20
ROE % 28.65
ROCE % 27.90
Total Debt to Total Equity 0.08
EBITDA Margin 27.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.07
ROE % 43.59
ROCE % 32.08
Total Debt to Total Equity 0.10
EBITDA Margin 32.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 39.65
ROE % 25.36
ROCE % 29.06
Total Debt to Total Equity 0.09
EBITDA Margin 32.95
Particulars MAR 2020 (Values in Cr)
Book Value / Share 40.24
ROE % 15.50
ROCE % 18.22
Total Debt to Total Equity 0.08
EBITDA Margin 27.53
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 201.38
Total Assets 3279.70
Total Liabilities 3279.70
Total Equity 2457.71
Share Outstanding 436500000
Price to Book Ratio 7.86
Return on Assets (%) 22.06
Return on Capital (%) 28.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 184.74
Total Assets 3109.85
Total Liabilities 3109.85
Total Equity 2312.76
Share Outstanding 441150000
Price to Book Ratio 6.98
Return on Assets (%) 20.56
Return on Capital (%) 26.8
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 116.00
Total Assets 3057.48
Total Liabilities 3057.48
Total Equity 2074.29
Share Outstanding 441150000
Price to Book Ratio 9.47
Return on Assets (%) 27.44
Return on Capital (%) 35.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 360.37
Total Assets 2519.68
Total Liabilities 2519.68
Total Equity 1761.76
Share Outstanding 444513740
Price to Book Ratio 12.32
Return on Assets (%) 18.04
Return on Capital (%) 24.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 119.05
Total Assets 2678.48
Total Liabilities 2678.48
Total Equity 1822.88
Share Outstanding 453180768
Price to Book Ratio 4.28
Return on Assets (%) 11.30
Return on Capital (%) 14.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 91.14
Total Assets 2846.66
Total Liabilities 2846.66
Total Equity 2382.97
Share Outstanding 436500000
Price to Book Ratio 7.86
Return on Assets (%) 24.35
Return on Capital (%) 29.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 95.79
Total Assets 2751.37
Total Liabilities 2751.37
Total Equity 2263.69
Share Outstanding 441150000
Price to Book Ratio 6.98
Return on Assets (%) 20.84
Return on Capital (%) 25.22
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 55.60
Total Assets 2825.88
Total Liabilities 2825.88
Total Equity 2085.95
Share Outstanding 441150000
Price to Book Ratio 9.47
Return on Assets (%) 30.10
Return on Capital (%) 37.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 307.92
Total Assets 2304.09
Total Liabilities 2304.09
Total Equity 1759.32
Share Outstanding 444513740
Price to Book Ratio 12.32
Return on Assets (%) 20.62
Return on Capital (%) 26.31
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 57.29
Total Assets 2434.77
Total Liabilities 2434.77
Total Equity 1801.99
Share Outstanding 453180768
Price to Book Ratio 4.28
Return on Assets (%) 11.87
Return on Capital (%) 14.75
Particulars MAR 2024 (Values in Cr)
Net Income 790.83
Cash from Operations 925.29
Cash from Investing -205.39
Cash from Financing -562.96
Net change in Cash 6.16
Free Cash Flow 965.88
Particulars MAR 2023 (Values in Cr)
Net Income 669.54
Cash from Operations 865.91
Cash from Investing -112.82
Cash from Financing -607.64
Net change in Cash 16.10
Free Cash Flow 906.37
Particulars MAR 2022 (Values in Cr)
Net Income 688.00
Cash from Operations 786.44
Cash from Investing -234.90
Cash from Financing -402.13
Net change in Cash 7.69
Free Cash Flow 1270.01
Particulars MAR 2021 (Values in Cr)
Net Income 568.92
Cash from Operations 1007.99
Cash from Investing -226.94
Cash from Financing -688.17
Net change in Cash 8.97
Free Cash Flow 1041.68
Particulars MAR 2020 (Values in Cr)
Net Income 373.57
Cash from Operations 606.72
Cash from Investing -227.68
Cash from Financing -405.35
Net change in Cash -105.62
Free Cash Flow 765.80
Particulars MAR 2024 (Values in Cr)
Net Income 746.64
Cash from Operations 870.55
Cash from Investing -192.28
Cash from Financing -546.11
Net change in Cash 1.39
Free Cash Flow 901.98
Particulars MAR 2023 (Values in Cr)
Net Income 606.32
Cash from Operations 838.94
Cash from Investing -105.58
Cash from Financing -612.17
Net change in Cash 13.19
Free Cash Flow 870.77
Particulars MAR 2022 (Values in Cr)
Net Income 689.06
Cash from Operations 725.99
Cash from Investing -187.90
Cash from Financing -398.06
Net change in Cash 9.88
Free Cash Flow 1203.35
Particulars MAR 2021 (Values in Cr)
Net Income 574.21
Cash from Operations 944.43
Cash from Investing -199.95
Cash from Financing -678.76
Net change in Cash -0.32
Free Cash Flow 977.36
Particulars MAR 2020 (Values in Cr)
Net Income 337.85
Cash from Operations 610.47
Cash from Investing -251.39
Cash from Financing -399.16
Net change in Cash -104.77
Free Cash Flow 764.52
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5419.75 60.01 40.66 130544.59 4506.50 / 6473.10
NESTLE INDIA LIMITED 2414.20 75.80 58.04 232766.82 2115.00 / 2777.00
FOODS & INNS LIMITED 89.21 27.03 1.27 654.93 75.20 / 174.70
HINDUSTAN UNILEVER LTD. 2331.60 52.56 11.08 547830.70 2136.00 / 3034.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5419.75 61.52 47.06 130544.59 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2667.35 49.63 43.89 72548.09 2324.00 / 3893.00
NESTLE INDIA LIMITED 2414.20 75.14 56.53 232766.82 2115.00 / 2777.00
FOODS & INNS LIMITED 89.21 26.01 1.26 654.93 75.20 / 174.70

EMAMI LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
619.80 -4.02 redarrow
red-green-graph indicator
5 Bearish
11 Bullish
  • 5 Days 630.30
  • 26 Days 599.30
  • 10 Days 621.80
  • 50 Days 588.10
  • 12 Days 618.20
  • 100 Days 596.10
  • 20 Days 605.90
  • 200 Days 608.80
643.72 PIVOT

First Support

635.48

First Resistance

654.03

Second Support

625.17

Second Resistance

662.27

Third Support

616.93

Third Resistance

672.58

RSI

57.27

ADX

24.77

MACD

18.94

Williams % R

-31.71

Commodity Channel Index (CCI)

88.97

Date

2025-04-25

Week

184988.00

Same Day

200743.00

Month

254757.00

1 Year

0.63

3 Year

0.56

Over 1 Month

7.59%

down

Over 1 Year

33.29%

down

Over 3 Months

15.83%

down

Over 3 Years

8.49%

down

Over 6 Months

-3.98%

down

Over 5 Years

25.37%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

EMAMI LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
9.37%
Promoter Holdings
54.84%
FII
12.1%
DII
23.67%
Promoter Shares(Pledge Percentage)
13.39%
Name Shares Category
Suraj Finvest Private Limited 1.05720226E8 (24.22%) Shareholding of Promoter and Promoter Group
Diwakar Finvest Private Limited 9.8667956E7 (22.6%) Shareholding of Promoter and Promoter Group
Dsp Aggressive Hybrid Fund 1.6458306E7 (3.77%) Public Shareholding
Priti A Sureka 1.5104702E7 (3.46%) Shareholding of Promoter and Promoter Group
Kotak Emerging Equity Scheme 1.4726311E7 (3.37%) Public Shareholding
Hdfc Large And Mid Cap Fund 1.3779069E7 (3.16%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Etf Nifty Midcap 150 1.3731464E7 (3.15%) Public Shareholding
Avees Trading And Finance Pvt Ltd 8721953.0 (2.0%) Public Shareholding
Franklin India Multi Cap Fund 7647250.0 (1.75%) Public Shareholding
Sbi Large & Midcap Fund 7554125.0 (1.73%) Public Shareholding
Uti Aggressive Hybrid Fund 6108813.0 (1.4%) Public Shareholding
Pinebridge Global Funds - Pinebridge India Equity Fund 4610997.0 (1.06%) Public Shareholding
Pan Emami Cosmed Limited 3117160.0 (0.71%) Shareholding of Promoter and Promoter Group
Avishi Sureka 1400000.0 (0.32%) Shareholding of Promoter and Promoter Group
Emami Paper Mills Ltd 933000.0 (0.21%) Shareholding of Promoter and Promoter Group
Sachin Goenka 717000.0 (0.16%) Shareholding of Promoter and Promoter Group
Shobhana Agarwal 630000.0 (0.14%) Shareholding of Promoter and Promoter Group
Amitabh Goenka 571496.0 (0.13%) Shareholding of Promoter and Promoter Group
Advay Goenka 554000.0 (0.13%) Shareholding of Promoter and Promoter Group
Darsh Goenka 565000.0 (0.13%) Shareholding of Promoter and Promoter Group
Manan Goenka 565000.0 (0.13%) Shareholding of Promoter and Promoter Group
Vibhash Vardhan Agarwal 573478.0 (0.13%) Shareholding of Promoter and Promoter Group
Sashwat Goenka 580000.0 (0.13%) Shareholding of Promoter and Promoter Group
Jyoti Agarwal 488000.0 (0.11%) Shareholding of Promoter and Promoter Group
Ritu Goenka 454930.0 (0.1%) Shareholding of Promoter and Promoter Group
Radheshyam Goenka 415876.0 (0.1%) Shareholding of Promoter and Promoter Group
Chikky Goenka 371700.0 (0.09%) Shareholding of Promoter and Promoter Group
Devarsh Goenka 407750.0 (0.09%) Shareholding of Promoter and Promoter Group
Reyansh Goenka 407750.0 (0.09%) Shareholding of Promoter and Promoter Group
Ashish Goenka 284400.0 (0.07%) Shareholding of Promoter and Promoter Group
Rajkumar Goenka 302364.0 (0.07%) Shareholding of Promoter and Promoter Group
Rachana Goenka 317700.0 (0.07%) Shareholding of Promoter and Promoter Group
Yogesh Goenka 245400.0 (0.06%) Shareholding of Promoter and Promoter Group
Nikunj Goenka 265000.0 (0.06%) Shareholding of Promoter and Promoter Group
Nimisha Goenka 244000.0 (0.06%) Shareholding of Promoter and Promoter Group
Indu Goenka 269700.0 (0.06%) Shareholding of Promoter and Promoter Group
Rachna Bagaria 270000.0 (0.06%) Shareholding of Promoter and Promoter Group
Aditya Vardhan Agarwal Huf 204278.0 (0.05%) Shareholding of Promoter and Promoter Group
Saroj Goenka 215240.0 (0.05%) Shareholding of Promoter and Promoter Group
Shreya Goenka 230000.0 (0.05%) Shareholding of Promoter and Promoter Group
Reha Goenka 240000.0 (0.05%) Shareholding of Promoter and Promoter Group
Jayant Goenka 156254.0 (0.04%) Shareholding of Promoter and Promoter Group
Puja Goenka 169398.0 (0.04%) Shareholding of Promoter and Promoter Group
Vihan Vardhan Agarwal 172000.0 (0.04%) Shareholding of Promoter and Promoter Group
Harsha Vardhan Agarwal Huf 172000.0 (0.04%) Shareholding of Promoter and Promoter Group
Usha Agarwal 173096.0 (0.04%) Shareholding of Promoter and Promoter Group
Sushil Kumar Goenka Huf 174000.0 (0.04%) Shareholding of Promoter and Promoter Group
Manish Goenka Huf 174000.0 (0.04%) Shareholding of Promoter and Promoter Group
Mohan Goenka Huf 174000.0 (0.04%) Shareholding of Promoter and Promoter Group
Smriti Agarwal 184000.0 (0.04%) Shareholding of Promoter and Promoter Group
Prashant Goenka 190000.0 (0.04%) Shareholding of Promoter and Promoter Group
Radheshyam Agarwal 195000.0 (0.04%) Shareholding of Promoter and Promoter Group
Shruti Goenka 196130.0 (0.04%) Shareholding of Promoter and Promoter Group
Harsha Vardhan Agarwal 112116.0 (0.03%) Shareholding of Promoter and Promoter Group
Sushil Kumar Goenka 114300.0 (0.03%) Shareholding of Promoter and Promoter Group
Santosh Goenka 115640.0 (0.03%) Shareholding of Promoter and Promoter Group
Rashmi Goenka 121400.0 (0.03%) Shareholding of Promoter and Promoter Group
Aditya Vardhan Agarwal 134668.0 (0.03%) Shareholding of Promoter and Promoter Group
Manish Goenka 142196.0 (0.03%) Shareholding of Promoter and Promoter Group
Mansi Agarwal 150000.0 (0.03%) Shareholding of Promoter and Promoter Group
Amitabh Goenka Huf 74000.0 (0.02%) Shareholding of Promoter and Promoter Group
Prashant Goenka Huf 74000.0 (0.02%) Shareholding of Promoter and Promoter Group
Jayant Goenka Huf 74000.0 (0.02%) Shareholding of Promoter and Promoter Group
Ashish Goenka Huf 74000.0 (0.02%) Shareholding of Promoter and Promoter Group
Vidula Agarwal 80000.0 (0.02%) Shareholding of Promoter and Promoter Group
Vidhishree Agarwal 80000.0 (0.02%) Shareholding of Promoter and Promoter Group
Abhishek Agarwal 84000.0 (0.02%) Shareholding of Promoter and Promoter Group
Richa Agarwal 93222.0 (0.02%) Shareholding of Promoter and Promoter Group
Laxmi Devi Bajoria 106000.0 (0.02%) Shareholding of Promoter and Promoter Group
Shubham Agarwal 24460.0 (0.01%) Shareholding of Promoter and Promoter Group
Sangita Agarwal 26000.0 (0.01%) Shareholding of Promoter and Promoter Group
Divya Agarwal 26000.0 (0.01%) Shareholding of Promoter and Promoter Group
Pradip Kumar Agarwal 31150.0 (0.01%) Shareholding of Promoter and Promoter Group
Kusum Agarwal 34450.0 (0.01%) Shareholding of Promoter and Promoter Group
Jyoti Goenka 48776.0 (0.01%) Shareholding of Promoter and Promoter Group
Mohan Goenka 61900.0 (0.01%) Shareholding of Promoter and Promoter Group
Emami Frank Ross Limited 10000.0 (0.0%) Shareholding of Promoter and Promoter Group
Rohin Raj Sureka 5000.0 (0.0%) Shareholding of Promoter and Promoter Group
Sumangal Agarwal 8200.0 (0.0%) Shareholding of Promoter and Promoter Group
Vishal Agarwal 8200.0 (0.0%) Shareholding of Promoter and Promoter Group
Dhiraj Agarwal 16750.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

EMAMI LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
16 Feb 2024 4.0 Interim 2 19 Feb 2024 Equity shares
15 Nov 2023 4.0 Interim 1 15 Nov 2023 Equity shares
13 Feb 2023 4.0 Interim 2 13 Feb 2023 Equity shares
18 Nov 2022 4.0 Interim 21 Nov 2022 Equity shares
10 Feb 2022 4.0 Interim 2 11 Feb 2022 Equity shares
08 Nov 2021 4.0 Interim 09 Nov 2021 Equity shares
04 Feb 2021 4.0 Interim 2 05 Feb 2021 Equity shares
12 Nov 2020 4.0 Interim 13 Nov 2020 Equity shares
26 Mar 2020 2.0 Interim 2 27 Mar 2020 Equity shares
14 Nov 2019 2.0 Interim 15 Nov 2019 Equity shares
31 Jul 2019 4.0 Final 02 Aug 2019 Equity shares
21 Jun 2018 7.0 Final 22 Jun 2018 Equity shares
26 Jul 2017 5.25 Final 28 Jul 2017 Equity shares
14 Mar 2017 1.75 Interim 15 Mar 2017 Equity shares
26 Jul 2016 7.0 Final 28 Jul 2016 Equity shares
28 Jul 2015 3.0 Final 30 Jul 2015 Equity shares
01 Aug 2014 4.0 Final 05 Aug 2014 Equity shares
01 Aug 2014 4.0 Interim 22 Sep 2014 Equity shares
24 Jan 2014 3.0 Interim 27 Jan 2014 Equity shares
26 Jun 2013 8.0 Final 27 Jun 2013 Equity shares
02 Aug 2012 4.0 Final 04 Aug 2012 Equity shares
02 Aug 2012 4.0 Special 04 Aug 2012 Equity shares
05 Aug 2011 3.5 Final 09 Aug 2011 Equity shares
21 Jul 2010 3.0 Final 23 Jul 2010 Equity shares
22 Dec 2009 4.5 Final 24 Dec 2009 Equity shares
18 Aug 2008 4.5 Final 21 Aug 2008 Equity shares
20 Sep 2007 1.0 Final 22 Sep 2007 Equity shares
22 Mar 2007 2.0 Interim 23 Mar 2007 Equity shares
22 Mar 2007 1.0 Special 23 Mar 2007 Equity shares
18 Aug 2005 0.0 Final 20 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
22 Jun 2018 21 Jun 2018 1:1
27 Jun 2013 26 Jun 2013 1:2
30 Mar 2004 26 Mar 2004 1:1
Ex-Date Old FV NEW FV Record Date
21 Jul 2010 2.0 1.0 23 Jul 2010
16 Feb 2004 10.0 2.0 24 Feb 2004
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
16 Feb 2024 4.0 Interim 2 19 Feb 2024 Equity shares
15 Nov 2023 4.0 Interim 1 15 Nov 2023 Equity shares
13 Feb 2023 4.0 Interim 2 13 Feb 2023 Equity shares
18 Nov 2022 4.0 Interim 21 Nov 2022 Equity shares
10 Feb 2022 4.0 Interim 2 11 Feb 2022 Equity shares
08 Nov 2021 4.0 Interim 09 Nov 2021 Equity shares
04 Feb 2021 4.0 Interim 2 05 Feb 2021 Equity shares
12 Nov 2020 4.0 Interim 13 Nov 2020 Equity shares
26 Mar 2020 2.0 Interim 2 27 Mar 2020 Equity shares
14 Nov 2019 2.0 Interim 15 Nov 2019 Equity shares
31 Jul 2019 4.0 Final 02 Aug 2019 Equity shares
21 Jun 2018 7.0 Final 22 Jun 2018 Equity shares
26 Jul 2017 5.25 Final 28 Jul 2017 Equity shares
14 Mar 2017 1.75 Interim 15 Mar 2017 Equity shares
26 Jul 2016 7.0 Final 28 Jul 2016 Equity shares
28 Jul 2015 3.0 Final 30 Jul 2015 Equity shares
01 Aug 2014 4.0 Final 05 Aug 2014 Equity shares
01 Aug 2014 4.0 Interim 22 Sep 2014 Equity shares
24 Jan 2014 3.0 Interim 27 Jan 2014 Equity shares
26 Jun 2013 8.0 Final 27 Jun 2013 Equity shares
02 Aug 2012 4.0 Final 04 Aug 2012 Equity shares
02 Aug 2012 4.0 Special 04 Aug 2012 Equity shares
05 Aug 2011 3.5 Final 09 Aug 2011 Equity shares
21 Jul 2010 3.0 Final 23 Jul 2010 Equity shares
22 Dec 2009 4.5 Final 24 Dec 2009 Equity shares
18 Aug 2008 4.5 Final 21 Aug 2008 Equity shares
20 Sep 2007 1.0 Final 22 Sep 2007 Equity shares
22 Mar 2007 2.0 Interim 23 Mar 2007 Equity shares
22 Mar 2007 1.0 Special 23 Mar 2007 Equity shares
18 Aug 2005 0.0 Final 20 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
22 Jun 2018 21 Jun 2018 1:1
27 Jun 2013 26 Jun 2013 1:2
30 Mar 2004 26 Mar 2004 1:1
Ex-Date Old FV NEW FV Record Date
21 Jul 2010 2.0 1.0 23 Jul 2010
16 Feb 2004 10.0 2.0 24 Feb 2004

EMAMI LIMITED Share Price

Emami Limited was incorporated on March 11, 1983 with the name 'AMP Udyog Viniyog Limited'. Initially, R S Agarwal and R S Goenka set up a cosmetic manufacturing unit in Kolkata in 1974 under the name of Kemco Chemicals, a partnership firm. The cosmetic products, as well as Ayurvedic medicines, manufactured by the unit were marketed under the brand name of Emami. In the year 1978, Himani Ltd, a sick unit, was taken over by the Group and the new management decided to produce different types of health care items and toiletries with Ayurvedic preparation.

In the year 1994, Himani Limited was then merged with AMP Udyog Viniyog Limited and the name was changed to Himani Limited with effect from May 5, 1994. In the year 1995, Kemco Chemicals, the partnership firm was converted into a public limited company under the name and style of Emami Limited with effect from April 1, 1995. In the year 1998, Emami Limited was then merged with Himani Limited and the name was changed to Emami Limited with effect from September 1, 1998.

Emami Limited is one of India's leading FMCG companies engaged in manufacturing & marketing of personal care & healthcare products. Emami is the flagship company of the diversified Emami Group. The company sells over 300 diverse products. Emami's portfolio includes brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, & Mentho Plus Balm, Dermicool and others.

The company's product categories consists hair care, skin creams, soaps and lotions, talcum powder and ayurvedic healthcare products. Their product portfolio includes Navratna Oil, Boroplus Antiseptic Cream, Fair and Handsome, Navratna Cool Talc, Sona Chandi Chyawanprash, Zandu Balm, Himani Fast Relief, Emami Healthy & Fair, Emami Malai Kesar Cold Cream, Lalima, Sardi Ja and Zandu Pancharishta.

Emami products are available in over 9.4 lac retail outlets across India through its network of 3,150 distributors and its global footprint spans over 60 countries including GCC, Europe, Africa, CIS countries & the SAARC.

Emami has 8 manufacturing units across India. The company has ultra modern manufacturing facilities at Kolkata (West Bengal), Guwahati (Assam), Pantnagar (Uttarakhand), Vapi (Gujarat), Silvassa (Dadra & Nagar Haveli) and Talasari (Maharashtra). They have adopted the Total Quality Management system and all their manufacturing facilities have received cGMP and ISO 9001:2000 certifications. The company has 1 overseas unit in Bangladesh.

In the year 2000, the company's investment undertaking was de-merged into Pan Emami Cosmed Ltd with a view to concentrate on their core FMCG business. In the year 2003, the company set up a new unit at Amingaon, Guwahati. Also, they obtained the certificate of Good Manufacturing Practices for its Pondicherry Units.

During the year 2005-06, the company started a third party manufacturing unit in Baddi in Himachal Pradesh. They set up a wholly owned subsidiary company, namely Emami International FZE, in UAE, to expand their foreign market. In response to the marketplace reality, the company launched 'Navratna' cool talc, an extension of its hugely popular 'cool' oil brand

During the year 2006-07, the company launched Fair and Handsome Fairness Cream for men, Fair & Ageless Fairness Cream, Boroplus Antiseptic Light Cream and Body Lotion and Mr. Black and Mrs. Black, herbal Hair Dye Powder and Malai Kesar Cold Cream in the personal care segment. Also, they launched Sona Chandi Healthy and Fair Baby Massage Oil, Good Morning, an Ayurvedic laxative Churna, Sardi Ja, a cough syrup and Vaporub and Memo-plus, a memory booster, Sanjeevan Dhara - a digestive in the market.

During the year, as per the scheme of amalgamation, JB Marketing & Finance Ltd, the erstwhile marketing company of the Emami Group was amalgamated with the company. The equity shares of the company were listed on the National Stock Exchange Ltd. In May 2007, the company formed a wholly owned subsidiary company namely, Emami Realty Pvt Ltd. The company ventured into the realty business through this wholly owned subsidiary company.

In November 2008, the company acquired 68.9% stake in Zandu Pharmaceutical Works Ltd at a consideration of Rs 713 crore and de-merged Zandu's FMCG business into the company. Simultaneously, real estate undertaking of the company comprising of their interest into Emami Realty Ltd and Zandu's non-core business comprising real estate was de-merged into Emami Infrastructure Ltd with effect from November 05, 2008.

During the year 2009-10, the company launched new products namely, Boroplus Winter Lotion and Emami Malai Kesar Soap in the market. Also, they launched new product variants, Navratna Oil. They introduced Zandu Balm in a new bicolour plastic container. They opened a new depot in Coimbatore to widen South India sales. Also, they commenced operations in Bangladesh.

In 2010, the company's net sales crossed of Rs 1000 crore milestone. During the year, the company carried out a stock split from Rs 2 to Re 1 per share.

During 2011-12, the company increased its direct rural reach. The direct retail coverage increased to 5 lac outlets. During the year, the company initiated Bangladesh and Egypt units which are expected to become operational in 2012-13. During the year, the company upgraded the ayurvedic manufacturing facility at the BT Road unit as per WHO guidelines. The company also completed capacity expansion at its Pantnagar unit. During the year, the company completed integration of the southern distribution channel of Zandu with Emami. The company also enhanced focus on the marketing activities of healthcare products of Zandu.

During 2012-13, the company fortified its direct rural reach across 600,000 outlets. During the year, the company's Bangladesh unit became operational. In 2013, the company launched BoroPlus Face wash.

During 2013-14, the company expanded capacity at its Pantnagar and Amingaon facilities. The Vapi plant was revamped to match the WHO-GMP standards. During the year, the company increased direct retail presence among 625,000 retailers. During the year, both the Research & Innovation (R&I) centres at Kolkata and Mumbai facility became fully operational. On the overseas front, Emami started manufacturing oil at its Bangladesh plant during the year.

In 2014, the company entered the male deodorants space with its brand HE. It also launched Fair & Handsome- Instant Fairness Face wash. Also during the year, the company acquired 'She Comfort' brand of sanitary napkin from Mumbai-based Royal Hygiene Care, marking its foray into the feminine hygiene space.

During 2014-15, Emami undertook capacity expansion initiatives across various units for various products. The company augmented Navratna Oil, BoroPlus Lotion and Vasocare Petroleum Jelly capacities at its Abhoypur plant and enhanced Pancharishtha capacity by 17% at its Vapi unit. During the year, the company started manufacturing Navratna Oil at its Dongari manufacturing plant to cater to export requirements. During the year, Emami initiated setting up a new manufacturing unit under the North-East mega project scheme which is expected to commence operations in FY 2016. The company launched 4 new products during the year. During the year, Emami acquired Fravin Pty Ltd, an Australian organic personal care product major with proven expertise in the realm of R&D, to gain a strong foothold in the highly regulated Australian market.

In June 2015, the company acquired Ayurvedic Hair & scalp business of 'Kesh King' at Rs 1684 crore (including duties & taxes). It also acquired controlling stake in Fravin Pty Ltd.

During 2015-16, Emami invested Rs 150 crore to build a new plant in Assam, which is expected to commence operations by FY 2017. The planned total outlay for the unit is Rs 300 crore. During the year, the company increased direct retail reach to more than 6.4 lac outlets and direct coverage to 13,300 villages with a population less than 50,000.

On 25 January 2016, Zandu Ayurveda, from the house of Emami Limited, announced the launch of Zandu Pure Honey without added sugar in the Indian market.

On 8 August 2016, Emami announced the reintroduction of its pain solution balm Zandu Balm with a new and advanced formulation offering a more effective and faster pain solution.

Emami's 3rd manufacturing unit at Pacharia, Assam was formally inaugurated on 14 November 2017. Located at Pacharia in the Kamrup district of Assam and spread over 34 acres of land, the new plant of the company is the largest production facility of Emami in India. This new facility of Emami Limited is a world-class facility which is designed to spread over a total planned floor area of over 50,000 sq.mt for a total production capacity of 90,000 MTPA. Raw material for the plant will be sourced both from indigenous and overseas locations as per the requirement. Total investment incurred for the new facility is over Rs 300 crore.

On 7 December 2017, Emami announced a strategic investment in Helios Lifestyle Pvt Ltd (Helios) with an acquisition of 30% equity stake for an undisclosed consideration. Helios owns the fast-growing male grooming brand 'The Man Company'. The equity stake will be acquired by 31 December 2018 through infusion of required funds in Helios. 'The Man Company'(TMC) offers a head-to-toe range of premium men's grooming products in Bath & Body, Beard management, Shaving & Perfumes category. The products are currently sold online majorly through the company's own website - www.themancompany.com. All the products are based on premium essential oils and are free of harmful chemicals. The acquisition of stake by Emami is significant as it marks the company's entry in the fast growing online male grooming segment.

On 5 February 2018, Emami Limited announced that it has entered into an agreement for strategic investment in Brillare Science Pvt Ltd (Brillare) through compulsory convertible preference shares (CCPS), which on conversion will result in 26% equity stake in Brillare basis the achievement of agreed future performance of the company. Brillare owns the premium hair & skin care portfolio for use in professional salons. Brillare also provides customised beauty treatment which enables salon professionals to treat multiple hair & skin concerns simultaneously.

During the year 2018-19, the Company acquired a leading personal care products, Creme 21, a German brand. It launched personal and healthcare products like Fair and Handsome 5-in-1 Pimple Clear Instant Fairness Facewash, HE Magic Duo Deodorant, Striveda
Lactation Supplement and Zandu Diabrishta - 21. It also launched variants of HE Deodorants (HE Intense Body Spray), Diamond Shine
Hair Colour (burgundy) and Navratna Smart Cool (Dynamite & Force). It launched the Rahat Raja' television commercial to present Navratna as an antidote beyond the usual to sleeplessness, body ache and the premature greying of hair. It launched HE Magic Duo with a packaging innovation, combining two different fragrances in one bottle. It relaunched Fair & Handsome in innovative packaging. It launched Kesh King Oil with a differentiated special comb applicator to drive equity and consumer convenience.

During year 2019-20, it relaunched key brands like Navratna Cool Talc, Zandu Pancharishta and BoroPlus lotions. It extended Emami's international presence to nearly 60 countries. It integrated the acquired Creme 21 brand into Emami's distribution network. It had 10 subsidiaries as of 31st March, 2020.

During the year 2019-20, Company launched an extension 'Navratna' brand with Navratna Garam Oil to target lapsers in winters, offering solutions for headache, numbness and lethargy. It launched innovative products like Zandu Ayurvedic Cough Syrup, HE Magic Duo and Zandu Anand Balm in the domestic business. For the International markets, it launched new variants of Emami 7 Oils in One
and a Perfect Derma Range under the BoroPlus brand.

In 2020-21, Emami launched BoroPlus Organic Aloe Vera Gel, BoroPlus Hygiene range, EMASOL Home Hygiene range and various healthcare products under Zandu, which mitigates seasonal impact. It localised the supply chain in Bangladesh and contract manufacturing in Germany, Sri Lanka and Dubai, launched the entire range of oils in Bangladesh including Navratna Oil, 7 Oils in One and Kesh King, introduced Creme 21 in Bangladesh, launched health, hygiene and immunity boosting products, introduced localised herbal products while enhancing ayurveda globalisation, in regions like MENA, Bangladesh, Russia, Nepal. The Company introduced more than 50 new products and variants, majorly in the health and hygiene categories during the year. BoroPlus, with its nation-wide strong brand equity for its antiseptic and germ protection properties introduced a personal hygiene range consisting of Hand Sanitizer, Antiseptic Soap, Antiseptic Handwash, Hygiene Liquid and Body wash which received a very encouraging market response. Under the Zandu Healthcare range, the Company introduced Zandu Ayurvedic Sanitizer, Zandu Ortho Vedic Pain relief oil, Zandu
Ayush Kwath Powder, Zandu Single herbs range, Zandu Immu Soft Chews, Zandu Health Juices, Zandu Tulsi and Haldi Drops, among others. It launched a new brand 'EMASOL' which offers a complete range of home hygiene products, with the unique proposition of 24 hr protection. It launched 'Immune India offer' to make Zandu Immunity boosters affordable for Indians and help them boost their immunity. The Company had 8 subsidiaries as of 31 March, 2021.

In March 2022, the Company acquired Dermicool', one of the leading brands in Prickly Heat and Cool Talc Segment from Reckitt Benckiser Healthcare India Pvt. Ltd. costing Rs 432 crore. It acquired a 20.65% equity stake in Tru Native F&B Pvt. Ltd., that markets nutrition products. It increased stake in the associate Company, Helios Lifestyle Pvt. Ltd from 33.09% to 49.53%.

In year 2021-22, Brillare Science Private Limited became a subsidiary of the Company w.e.f. 1st October, 2021.

During 2022-23, Helios Lifestyle Private Limited became a subsidiary of Emami Limited w.e.f 1st July, 2022. Emami International Personal Care Trading LLCUAE, wholly owned subsidiary of the Company incorporated on January 28, 2022 was made the Wholly Owned Subsidiary of Emami international FZE w.e.f. February 15, 2022.

In 2024, Company entered the juice category through a strategic investment in Axiom Ayurveda Pvt Ltd, acquiring a 26% equity stake. It increased the stake in Brillare Science from 82.92% to 100%. It increased the distribution through Project Khoj resulted in an additional coverage of more than 20,000 towns in rural regions since the launch of the project. A cell-based model was developed for assessing wound healing efficacy, optimizing costs, and enabling effective claims for products. For haemorrhoids (piles), Zandu Pileave ointments and
tablets were developed as a comprehensive therapy tool for Ayurvedic practitioners. The Company launched more than 35 new products and variants during the year in the Domestic business, primarily as digital-first launches on its D2C portal, Zanducare. Overall, the Company has introduced more than 90 new product developments on Zanducare since its inception, showcasing a commitment to diversification and innovation.

Parent organization Emami Group
NSE symbol EMAMILTD
Founded 1983
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Emami Ltd?

Answer Field

The share price of Emami Ltd for NSE is ₹ 619.8 and for BSE is ₹ 621.5.

What is the Market Cap of Emami Ltd?

Answer Field

The market cap of Emami Ltd for NSE is ₹ 2,70,54.27 Cr. and for BSE is ₹ 2,71,28.47 Cr. as of now.

What is the 52 Week High and Low of Emami Ltd?

Answer Field

The 52 Week High and Low of Emami Ltd for NSE is ₹ 860.00 and ₹ 447.85 and for BSE is ₹ 859.20 and ₹ 449.15.

How to Buy Emami Ltd share?

Answer Field

You can trade in Emami Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Emami Ltd?

Answer Field

The 1 year returns on the stock has been 33.29%.

What is the Current Share Price of Emami Ltd?

Answer Field

Emami Ltd share price is for NSE ₹ 619.8 & for BSE ₹ 621.5 as on Apr 25 2025 03:30 PM.

What is the Market Cap of Emami Ltd Share?

Answer Field

The market cap of Emami Ltd for NSE ₹ 2,70,54.27 & for BSE ₹ 2,71,28.47 as on Apr 25 2025 03:30 PM.

What is the P/E Ratio of Emami Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM the price-to-earnings (PE) ratio for Emami Ltd share is 32.95.

What is the PB ratio of Emami Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM, the price-to-book (PB) ratio for Emami Ltd share is 63.54.

How to Buy Emami Ltd Share?

Answer Field

You can trade in Emami Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Emami Ltd Share on Bajaj Broking App?

Answer Field

To buy Emami Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Emami Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|